MentionFox
Home › 5%+ stakes › Manufacturing, latest filing in June 2026
5%+ stakes

Manufacturing, latest filing in June 2026

11 companies with 5%+ holders, every filing linked: Ads-Tec Energy Public Ltd Co, Brown-Forman Corporation, CorMedix Inc., Earth Science Tech, Inc., Global Innovative Platforms Inc., Innate Pharma SA and more. Each section is the company's full record from its filings, newest filings first within each section.

11 companies with 5%+ holders on this page (Manufacturing, latest filing in June 2026), each linked to its filing, starting with Ads-Tec Energy Public Ltd Co, Brown-Forman Corporation, CorMedix Inc.. Free check on any of them: https://mentionfox.com/check

On this page

Ads-Tec Energy Public Ltd Co

At 5% or more2
Filings4
Latest filing2026-06-04

Ads-Tec Energy Public Ltd Co has 4 Schedule 13D or 13G filings on record since 2025-07-09. 2 holders' latest filing reports 5% or more of class a common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Mirabella Financial Services LLP25.23%18,169,949SCHEDULE 13G/A, 2026-05-152026-04-30
Lucerne Capital Management LP22.9%17,159,341SCHEDULE 13D/A, 2026-06-042026-05-08
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Mirabella Financial Services LLP18,169,949018,169,9490SCHEDULE 13G/A, 2026-05-15
Lucerne Capital Management LP15,383,1171,776,22415,383,1171,776,224SCHEDULE 13D/A, 2026-06-04
Pieter Taselaar017,159,341017,159,341SCHEDULE 13D/A, 2026-06-04
Matheus Hovers017,159,341017,159,341SCHEDULE 13D/A, 2026-06-04
Jonathan Copplestone017,159,341017,159,341SCHEDULE 13D/A, 2026-06-04
Patrick Moroney017,159,341017,159,341SCHEDULE 13D/A, 2026-06-04

The latest filing identifies Ads-Tec Energy Public Ltd Co by CUSIP G0085J117 and gives its principal executive office as 10 EARLSFORT TERRACE, DUBLIN 2, DUBLIN (SCHEDULE 13D/A, 2026-06-04).

FiledHolderPercentFiling
2025-07-09Lucerne Capital Management LP20.5%SCHEDULE 13D
2026-05-12Mirabella Financial Services LLP30.22%SCHEDULE 13G/A
2026-05-15Mirabella Financial Services LLP25.23%SCHEDULE 13G/A
2026-06-04Lucerne Capital Management LP22.9%SCHEDULE 13D/A

Brown-Forman Corporation

At 5% or more2
Filings6
Latest filing2026-06-03

Brown-Forman Corporation has 6 Schedule 13D or 13G filings on record since 2025-11-05. 2 holders' latest filing reports 5% or more of class a common stock (voting), $0.15 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Wolf Pen Branch, LP60.3%101,601,480SCHEDULE 13D/A, 2026-06-032026-06-03
Vanguard Capital Management5.58%16,213,828SCHEDULE 13G, 2026-04-292026-03-31
Fmr LLC4.4%12,779,312SCHEDULE 13G/A, 2026-05-062026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Wolf Pen Branch, LP101,601,480—42,000,000—SCHEDULE 13D/A, 2026-06-03
Wolf Pen Branch GP, LLC101,601,480—42,000,000—SCHEDULE 13D/A, 2026-06-03
Vanguard Capital Management1,541,500016,213,8280SCHEDULE 13G, 2026-04-29
Fmr LLC7,408,620012,779,3120SCHEDULE 13G/A, 2026-05-06
Abigail P. Johnson0012,779,3120SCHEDULE 13G/A, 2026-05-06
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies Brown-Forman Corporation by CUSIP 115637100 and gives its principal executive office as 850 DIXIE HWY, LOUISVILLE, KY 40210 (SCHEDULE 13D/A, 2026-06-03).

FiledHolderPercentFiling
2025-11-05Fmr LLC7.5%SCHEDULE 13G
2026-02-05Fmr LLC8.7%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Capital Management5.58%SCHEDULE 13G
2026-05-06Fmr LLC4.4%SCHEDULE 13G/A
2026-06-03Wolf Pen Branch, LP60.3%SCHEDULE 13D/A
DateRecordFigureOur pageSource
July 13, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

CorMedix Inc.

At 5% or more2
Filings7
Latest filing2026-06-12

CorMedix Inc. has 7 Schedule 13D or 13G filings on record since 2025-08-08. 2 holders' latest filing reports 5% or more of common stock, par v alue $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Deep Track Capital, LP7.94%6,274,076SCHEDULE 13G/A, 2026-05-152026-03-31
Shaibatalhamd Aymen Abdalkader5.9%4,618,511SCHEDULE 13G/A, 2026-06-122026-06-11
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Deep Track Capital, LP06,274,07606,274,076SCHEDULE 13G/A, 2026-05-15
Deep Track Biotechnology Master Fund, Ltd.06,274,07606,274,076SCHEDULE 13G/A, 2026-05-15
David Kroin06,274,07606,274,076SCHEDULE 13G/A, 2026-05-15
Shaibatalhamd Aymen Abdalkader4,618,511—4,618,511—SCHEDULE 13G/A, 2026-06-12
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-26

The latest filing identifies CorMedix Inc. by CUSIP 21900C308 and gives its principal executive office as 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ 07054 (SCHEDULE 13G/A, 2026-06-12).

FiledHolderPercentFiling
2025-08-08Shaibatalhamd Aymen Abdalkader6.2%SCHEDULE 13G/A
2025-12-01Deep Track Capital, LP6.29%SCHEDULE 13G
2026-01-02Shaibatalhamd Aymen Abdalkader5.8%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-05-15Deep Track Capital, LP7.94%SCHEDULE 13G/A
2026-06-12Shaibatalhamd Aymen Abdalkader5.9%SCHEDULE 13G/A
2026-06-12Shaibatalhamd Aymen Abdalkader5.9%SCHEDULE 13G/A

Earth Science Tech, Inc.

At 5% or more1
Filings1
Latest filing2026-06-22

Earth Science Tech, Inc. has 1 Schedule 13D or 13G filing on record since 2026-06-22. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Giorgio R. Saumat42.94%123,737,006SCHEDULE 13G, 2026-06-222026-06-22
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Giorgio R. Saumat123,737,0060123,737,0060SCHEDULE 13G, 2026-06-22

The latest filing identifies Earth Science Tech, Inc. by CUSIP 270311103 and gives its principal executive office as 8950 SW 74th Court Suite 1401, Miami, FL 33156 (SCHEDULE 13G, 2026-06-22).

FiledHolderPercentFiling
2026-06-22Giorgio R. Saumat42.94%SCHEDULE 13G
DateRecordFigureOur pageSource
October 26, 2026Leadership change: Ernesto L. Flores departs, Chief Financial Officer, and 1 more—Leadership changesSource
November 13, 2024Form D, private offering$1.23M soldForm D pageSource
November 13, 2024Form D, private offering$350K soldForm D pageSource

Global Innovative Platforms Inc.

At 5% or more1
Filings1
Latest filing2026-06-10

Global Innovative Platforms Inc. has 1 Schedule 13D or 13G filing on record since 2026-06-10. 1 holder's latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Jones James Carl14.99%92,812SCHEDULE 13G, 2026-06-102021-03-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Jones James Carl92,812092,8120SCHEDULE 13G, 2026-06-10

The latest filing identifies Global Innovative Platforms Inc. by CUSIP 13767J104 and gives its principal executive office as 149 JAMES PLACE, MAITLAND, FL 32751 (SCHEDULE 13G, 2026-06-10).

FiledHolderPercentFiling
2026-06-10Jones James Carl14.99%SCHEDULE 13G
DateRecordFigureOur pageSource
October 6, 2026Leadership change: Andrew Brown departs, and 1 more—Leadership changesSource
June 4, 2026Form D, private offering—Form D pageSource
April 8, 2026Form D, private offering$157K soldForm D pageSource

Innate Pharma SA

At 5% or more1
Filings5
Latest filing2026-06-22

Innate Pharma SA has 5 Schedule 13D or 13G filings on record since 2025-10-21. 1 holder's latest filing reports 5% or more of ordinary shares, nominal value (euro) 0.05 per share (including ordinary shares represented by american depositary shares). Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
AstraZeneca PLC8.3%7,825,501SCHEDULE 13D/A, 2026-02-062025-12-22
Novo Nordisk A/S0%0SCHEDULE 13G/A, 2026-06-222026-05-29
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
AstraZeneca PLC7,825,50107,825,5010SCHEDULE 13D/A, 2026-02-06
MedImmune Limited7,825,50107,825,5010SCHEDULE 13D/A, 2026-02-06
Novo Nordisk A/S0000SCHEDULE 13G/A, 2026-06-22

The latest filing identifies Innate Pharma SA by CUSIP 45781K105 and gives its principal executive office as 117 Avenue de Luminy, BP 30191, Marseille (SCHEDULE 13G/A, 2026-06-22).

FiledHolderPercentFiling
2025-10-21Novo Nordisk A/S9.65%SCHEDULE 13G/A
2026-02-06AstraZeneca PLC8.3%SCHEDULE 13D/A
2026-03-04Novo Nordisk A/S7.82%SCHEDULE 13G/A
2026-04-10Novo Nordisk A/S5.03%SCHEDULE 13G/A
2026-06-22Novo Nordisk A/S0%SCHEDULE 13G/A

Maxeon Solar Technologies, Ltd.

At 5% or more1
Filings1
Latest filing2026-06-26

Maxeon Solar Technologies, Ltd. has 1 Schedule 13D or 13G filing on record since 2026-06-26. 1 holder's latest filing reports 5% or more of ordinary shares, no par value. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Whitebox Advisors LLC8.5%1,591,596SCHEDULE 13G, 2026-06-262026-06-15
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Whitebox Advisors LLC01,591,59601,591,596SCHEDULE 13G, 2026-06-26
Whitebox General Partner LLC01,591,59601,591,596SCHEDULE 13G, 2026-06-26

The latest filing identifies Maxeon Solar Technologies, Ltd. by CUSIP Y58473128 and gives its principal executive office as 8 Marina Boulevard #05-02, Marina Bay Financial Centre, Singapore (SCHEDULE 13G, 2026-06-26).

As of June 15, 2026, each of WA and WGP was deemed to beneficially own approximately 9.1% of the Ordinary Shares outstanding. As of the date hereof, each of WA and WGP is deemed to beneficially own approximately 8.5% of the Ordinary Shares outstanding.Whitebox Advisors LLC, SCHEDULE 13G, 2026-06-26
FiledHolderPercentFiling
2026-06-26Whitebox Advisors LLC8.5%SCHEDULE 13G

Owens Corning

At 5% or more3
Filings5
Latest filing2026-06-04

Owens Corning has 5 Schedule 13D or 13G filings on record since 2026-01-21. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.10%8,069,391SCHEDULE 13G/A, 2026-06-042026-05-31
Vanguard Portfolio Management6.88%5,532,481SCHEDULE 13G, 2026-04-292026-03-31
Vanguard Capital Management5.27%4,243,450SCHEDULE 13G, 2026-04-302026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.7,816,34308,069,3910SCHEDULE 13G/A, 2026-06-04
Vanguard Portfolio Management24,36005,532,4810SCHEDULE 13G, 2026-04-29
Vanguard Capital Management625,42204,243,4500SCHEDULE 13G, 2026-04-30
The Vanguard Group0000SCHEDULE 13G/A, 2026-03-27

The latest filing identifies Owens Corning by CUSIP 690742101 and gives its principal executive office as One Owens Corning Parkway, Toledo, OH 43659 (SCHEDULE 13G/A, 2026-06-04).

FiledHolderPercentFiling
2026-01-21BlackRock, Inc.9.6%SCHEDULE 13G/A
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-29Vanguard Portfolio Management6.88%SCHEDULE 13G
2026-04-30Vanguard Capital Management5.27%SCHEDULE 13G
2026-06-04BlackRock, Inc.10%SCHEDULE 13G/A
DateRecordFigureOur pageSource
September 16, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
July 29, 2026Leadership change: Jonathan M. Collins appointed, Chief Financial Officer, and 1 more—Leadership changesSource
May 1, 2026Leadership change: Todd W. Fister appointed, Chief Financial and Operating Officer—Leadership changesSource

Qiagen N.V.

At 5% or more2
Filings6
Latest filing2026-11-06

Qiagen N.V. has 6 Schedule 13D or 13G filings on record since 2025-08-12. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.10%20,678,987SCHEDULE 13G, 2026-02-062026-01-31
Massachusetts Financial Services Company6%12,447,526SCHEDULE 13G/A, 2026-06-052026-05-29
Wellington Management Group LLP0.9%1,869,523SCHEDULE 13G/A, 2026-11-062026-10-30
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.19,575,569020,678,9870SCHEDULE 13G, 2026-02-06
Massachusetts Financial Services Company11,469,431012,447,5260SCHEDULE 13G/A, 2026-06-05
Wellington Management Group LLP01,749,91701,869,523SCHEDULE 13G/A, 2026-11-06
Wellington Group Holdings LLP01,749,91701,869,523SCHEDULE 13G/A, 2026-11-06
Wellington Investment Advisors Holdings LLP01,749,91701,869,523SCHEDULE 13G/A, 2026-11-06

The latest filing identifies Qiagen N.V. by CUSIP N72482156 and gives its principal executive office as Hulsterweg 82, Venlo (SCHEDULE 13G/A, 2026-11-06).

FiledHolderPercentFiling
2025-08-12Wellington Management Group LLP12%SCHEDULE 13G/A
2025-11-12Wellington Management Group LLP10.7%SCHEDULE 13G/A
2026-02-06BlackRock, Inc.10%SCHEDULE 13G
2026-02-10Wellington Management Group LLP6.5%SCHEDULE 13G/A
2026-06-05Massachusetts Financial Services Company6%SCHEDULE 13G/A
2026-11-06Wellington Management Group LLP0.9%SCHEDULE 13G/A

Soligenix, Inc.

At 5% or more1
Filings5
Latest filing2026-11-02

Soligenix, Inc. has 5 Schedule 13D or 13G filings on record since 2025-10-01. 1 holder's latest filing reports 5% or more of common stock, par value $.001 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
MJL Manager LLC9.4%2,053,706SCHEDULE 13G/A, 2026-11-022026-09-30
Mitchell P. Kopin4.99%446,408SCHEDULE 13G, 2025-10-012025-09-25
Armistice Capital, LLC4.99%529,731SCHEDULE 13G/A, 2026-02-172025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
MJL Manager LLC02,053,70602,053,706SCHEDULE 13G/A, 2026-11-02
Michael Liu02,053,70602,053,706SCHEDULE 13G/A, 2026-11-02
Capuchin Capital Fund LP02,053,70602,053,706SCHEDULE 13G/A, 2026-11-02
Mitchell P. Kopin0446,4080446,408SCHEDULE 13G, 2025-10-01
Daniel B. Asher0446,4080446,408SCHEDULE 13G, 2025-10-01
Intracoastal Capital, LLC0446,4080446,408SCHEDULE 13G, 2025-10-01
Armistice Capital, LLC0529,7310529,731SCHEDULE 13G/A, 2026-02-17
Steven Boyd0529,7310529,731SCHEDULE 13G/A, 2026-02-17

The latest filing identifies Soligenix, Inc. by CUSIP 834223604 and gives its principal executive office as 29 EMMONS DRIVE, PRINCETON, NJ 08540 (SCHEDULE 13G/A, 2026-11-02).

FiledHolderPercentFiling
2025-10-01Mitchell P. Kopin4.99%SCHEDULE 13G
2025-11-14Armistice Capital, LLC6.72%SCHEDULE 13G
2026-02-17Armistice Capital, LLC4.99%SCHEDULE 13G/A
2026-06-25Michael Liu5.7%SCHEDULE 13G
2026-11-02MJL Manager LLC9.4%SCHEDULE 13G/A
DateRecordFigureOur pageSource
June 12, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

Tecogen Inc.

At 5% or more1
Filings2
Latest filing2026-06-10

Tecogen Inc. has 2 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of common stock, $0.001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Portolan Capital Management, LLC5.19%1,552,232SCHEDULE 13G, 2026-06-102026-06-03
Tryfon Natsis and Depoina Pantopoulou, as Joint Tenants with the Right of Survivorship1.8%460,300SCHEDULE 13G/A, 2025-08-142025-06-30
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Portolan Capital Management, LLC1,552,23201,552,2320SCHEDULE 13G, 2026-06-10
George McCabe1,552,23201,552,2320SCHEDULE 13G, 2026-06-10
Tryfon Natsis and Depoina Pantopoulou, as Joint Tenants with the Right of Survivorship0460,3000460,300SCHEDULE 13G/A, 2025-08-14

The latest filing identifies Tecogen Inc. by CUSIP 87876P201 and gives its principal executive office as 76 Treble Cove Road, North Billerica, MA 01862 (SCHEDULE 13G, 2026-06-10).

1.8% (based on 25,269,362 shares of Tecogen Inc. common stock outstanding as of May 20, 2025, as reported in Tecogen Inc.'s prospectus on Form 424B3 filed with the Securities and Exchange Commission on May 22, 2025).Tryfon Natsis and Depoina Pantopoulou, as Joint Tenants with the Right of Survivorship, SCHEDULE 13G/A, 2025-08-14
FiledHolderPercentFiling
2025-08-14Tryfon Natsis and Depoina Pantopoulou, as Joint Tenants with the Right of Survivorship1.8%SCHEDULE 13G/A
2026-06-10Portolan Capital Management, LLC5.19%SCHEDULE 13G

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All 5%+ stakes

RSS